Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Department of Pathology and Laboratory Science, Mount Sinai Hospital, Toronto, Ontario, Canada.
Genes Chromosomes Cancer. 2021 Jul;60(7):498-503. doi: 10.1002/gcc.22937. Epub 2021 Feb 2.
Recurrent fusions between OGT and members of the Forkhead box (FOXO) family of genes have been recently described in three cases of hyalinizing epithelioid acral soft tissue tumors in young adults showing co-expression for EMA and CD34. Despite the lack of an established myoepithelial lineage by immunohistochemistry, these lesions have been labeled as myoepithelioma-like due to their epithelioid phenotype and sclerotic background. In this study, we report a novel FOXO4-OGT fusion identified by targeted RNA sequencing in an unclassified shoulder soft tissue mass in a 40-year-old male. The tumor showed nodular foci of increased cellularity in a uniformly hyalinized background. The neoplastic cells were mainly epithelioid and focally spindled, with eosinophilic cytoplasm and indented nuclei with mild atypia. The tumor lacked significant mitotic activity and necrosis. Immunohistochemically, the tumor showed variable positivity for EMA, pan-CK, CD34, ERG and FLI1, while it was negative for CD31, S100, SOX10, desmin, and MUC4. INI1 expression was retained. Due to its unusual histology and conflicting immunoprofile, TruSight RNA fusion panel sequencing was performed which revealed a fusion between FOXO4 exon 2 to OGT exon 2. This is the first example of a soft tissue lesion harboring OGT-related fusions occurring in a non-acral location and associated with FOXO4 gene. Its line of differentiation and biologic potential remain uncertain.
最近在三例发生于年轻人的透明细胞样肢端软组织肿瘤中描述了 OGT 与叉头框(FOXO)家族基因成员之间的复发性融合,这些肿瘤表现为 EMA 和 CD34 的共表达。尽管免疫组织化学未能确立肌上皮谱系,但由于其上皮样表型和硬化背景,这些病变被标记为肌上皮瘤样。在这项研究中,我们报道了一例通过靶向 RNA 测序在 40 岁男性未分类肩部软组织肿块中发现的新型 FOXO4-OGT 融合。肿瘤在均匀的透明化背景下显示出结节状的细胞增多灶。肿瘤细胞主要为上皮样,局灶性梭形,胞质嗜酸性,核呈锯齿状,轻度异型性。肿瘤缺乏明显的有丝分裂活性和坏死。免疫组化显示,肿瘤对 EMA、pan-CK、CD34、ERG 和 FLI1 的表达呈可变阳性,而对 CD31、S100、SOX10、结蛋白和 MUC4 呈阴性。INI1 的表达保持不变。由于其不典型的组织学和相互矛盾的免疫组化表现,进行了 TruSight RNA 融合panel 测序,结果显示 FOXO4 外显子 2 与 OGT 外显子 2 之间发生融合。这是首例发生于非肢端部位并与 FOXO4 基因相关的软组织病变中存在 OGT 相关融合的病例。其分化途径和生物学潜能仍不确定。